课题基金 / 基金详情

PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE

PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE
阿片依赖的疼痛镇痛反应
批准号:
6261234
负责人:
WALTER NMN LING
金额:
$55.78万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2004-04-30

项目摘要

项目成果

WALTER NMN LING的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) There is an increasingly large population receiving opiates on a chronic basis, either for treatment of opiate dependence or for treatment of chronic pain. Managing pain in opiate maintained individuals is a challenging problem. The development of opioid tolerance and dependence may result in altered pain sensitivity and subsequent response to additional opioids. Many clinicians believe addicts cannot benefit from further opiate administration because they are tolerant to the analgesic effects. Others believe that if an addict is maintained on an opiate agonist, that medication provides adequate analgesia for acute pain. Patients are reluctant to give accurate histories because clinicians often withhold opioid analgesics from patients with a history of drug abuse. Those who do complain are viewed suspiciously and their complaints ignored. Currently there are few guidelines to assist clinicians and those that do exist are based on experience and consensus rather than evidence-based research. This study proposes to examine: 1) how patients on opiate maintenance (either buprenorphine or methadone) experience pain (tolerance and threshold) and how they are different from non-opiate dependent individuals, 2) how patients maintained on methadone and buprenorphine differ from normal controls in response to added opiate and non-opiate analgesics and 3) how therapeutic plasma concentration levels of morphine for analgesia differ in methadone and buprenorphine maintained patients compared to normal controls. The results of this proposed study will help develop systematic guidelines for clinicians in the management of pain in opiate maintained individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
Sustained-Release Methylphenidate For Management of Methamphetamine Use Disorders
海外基金